Fly News Breaks for March 9, 2015
MNK
Mar 9, 2015 | 07:39 EDT
Jefferies raised its price target for Mallinckrodt shares to $140 citing the company's acquisition of Ikaria. The firm believes Ikaria's positioning as the exclusive provider of inhaled nitric oxide for treating respiratory failure in newborns is secure at a minimum through 2017 patent expiries but likely significantly longer. It keeps a Buy rating on Mallinckrodt.
News For MNK From the Last 2 Days
There are no results for your query MNK